Efficacy of preoperative erythropoietin administration in pediatric neuromuscular scoliosis patients

Spine

Volumn 32, Issue 24, 2007, Pages 2662-2667

  Vitale, Michael G ^a,b,c,d   Privitera, David M ^a   Matsumoto, Hiroko ^a,b,c   Gomez, Jaime A ^a,b   Waters, Linda M ^a,b   Hyman, Joshua E ^a,b   Roye Jr , David P ^a,b  

^a Columbia University ^*  (United States)

^b NewYork Presbyterian Hospital   (United States)

^c NONE   (United States)

^d NONE   (United States)

Author keywords

Complications; Hematocrit; Pediatric neurogenic scoliosis; Recombinant human erythropoietin (rhEPO); The length of intensive care unit (ICU) days; Transfusion

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; COMORBIDITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; ERYTHROCYTE TRANSFUSION; FEMALE; HEMATOCRIT; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SCOLIOSIS; SPINE SURGERY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANEMIA; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HEMATOCRIT; HUMANS; MALE; MULTIVARIATE ANALYSIS; NEUROMUSCULAR DISEASES; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; SCOLIOSIS;

EID: 36248954913     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0b013e31815a59cf     Document Type: Article

References (45)

1. Guay J, Lortie L, Guertin MC, et al. Predicting blood loss in surgery for idiopathic scoliosis. Can J Anaesth 1994;41:775-81.
2. Vitale M, Stazzone E, Gelijns A, et al. The effectiveness of preoperative erythropoietin in averting allogenic blood transfusion among children undergoing scoliosis surgery. J Pediatr Orthop B 1998;7:203-9.
3. Vitale MG, Levy DE, Park MC, et al. Quantifying risk of transfusion in children undergoing spine surgery. Spine J 2002;2:166-72.
4. Shapiro GS, Boachie-Adjei O, Dhawlikar SH, et al. The use of Epoetin alfa in complex spine deformity surgery. Spine 2002;27:2067-71.
5. Nuttal GA, Horlocker TT, Santrach PJ, et al. Predictors of blood transfusions in spinal instrumentation and fusion surgery. Spine 2000;25:596-601.
6. Cowell HR, Swickard JW. Autotransfusion in children's orthopaedics. J Bone Joint Surg Am 1974;56:908-12.
7. Simpson MB, Georgopoulos G, Orsini E, et al. Autologous transfusions for orthopaedic procedures at a children's hospital. J Bone Joint Surg Am 1992;74:652-8.
8. Lee JH, Lee SH, Oh JH. Minimal effective dosage of recombinant human erythropoietin in spinal surgery. Clin Orthop Relat Res 2003;412:71-6.
9. Murray DJ, Forbes RB, Titone MB, et al. Transfusion management in pediatric and adolescent scoliosis surgery: efficacy of autologous blood. Spine 1997;22:2735-40.
10. Klein H. Allogeneic transfusion risks in the surgical patient. Am J Surg 1995;170:21S-26S.
11. Dodd RY. The risk of transfusion-transmitted infection [editorial]. N Engl J Med 1992;327:419-21.
12. Cowell HR. Perioperative red blood-cell tranfusion [editorial]. J Bone Joint Surg Am 1989;71:1-2.
13. McNeill TW, DeWald RL, Kuo KN, et al. Controlled hypotensive anesthesia in scoliosis surgery. J Bone Joint Surg Am 1974;56:1167-72.
14. Lisander B, Jonsson R, Nordwall A. Combination of blood-saving methods decreases homologous blood requirements in scoliosis surgery. Anaesth Intensive Care 1996;24:555-8.
15. Kobrinsky NL, Letts RM, Patel LR, et al. 1-Desamino-8-D-arginine vasopressin (desmopressin) decreases operative blood loss in patients having Harrington rod spinal fusion surgery. A randomized, double-blinded, controlled trial. Ann Intern Med 1987;107:446-50.
16. Lentschener C, Cottin P, Bouaziz H, et al. Reduction of blood loss and transfusion requirement by aprotinin in posterior lumbar spine fusion. Anesth Analg 1999;89:590-7.
17. Goodnough L, Vizmg K, Robecks R. Prevalence and classification of anemia in elective orthopaedic surgery patients: implications for blood conservation programs. Vox Sang 1992;63:90-5.
18. Han P, Stacy D. Response of the erythron and erythropoietin to autologous blood donations in paediatric subjects. Is erythropoietin supplement necessary? Vox Sang 1997;73:24-7.
19. Meert KL, Kannan S, Mooney JF. Predictors of red cell transfusion in children and adolescents undergoing spinal fusion surgery. Spine 2002;27:2137-42.
20. MacEwen G, Bennett E, Guille J. Autologous blood transfusions in children and young adults with low body weight undergoing spinal surgery. J Pediatr Orthop 1990;10:750-3.
21. Roye DP Jr. Commentary recombinant human erythropoietin and blood management in pediatric spine surgery. Orthopedics 1999;22:S158-S160.
22. Faris PM, Ritter MA, Abels RI. The effects of recombinant human erythropoietin on perioperative transfusion requirements in patients having a major orthopaedic operation. J Bone Joint Surg Am 1996;78:62-72.
23. Goodnough LT, Rudnick S, Price TH. Increased preoperative collection of autologous blood with recombinant human erythropoietin therapy. N Engl J Med 1989;321:1163-8.
24. Canadian Orthopedic Perioperative Erythropoietin Study Group. Effectiveness of perioperative recombinant human erythropoietin in elective hip replacement. Lancet 1993;341:1227-32.
25. Roye DP, Rothstein P, Rickert JB, et al. The use of preoperative erythropoietin in scoliosis surgery. Spine 1992;17:S204-S205.
26. Goodnough LT, Price TH, Friedman KD, et al. A phase III trial of recombinant human erythropoietin therapy in nonanaemic orthopedic patients subjected to aggressive removal of blood for autologous use: dose, response, toxicity, and efficacy. Transfusion 1994;34:66-71.
27. de Andrade J, Jobe M, Landon G, et al. Baseline hemoglobin as a predictor of risk of transfusion and response to Epoetin alfa in orthopedic surgery patients. Am J Orthop 1996;25:533-42.
28. Goldberg MA, McCutchen JW, Jove M, et al. A safety and efficacy comparison study of two dosing regimens of Epoetin alfa in patients undergoing major orthopedic surgery. Am J Orthop 1996;25:544-52.
29. Kannan S, Meert KL, Mooney JF, et al. Bleeding and coagulation changes during spinal fusion surgery: a comparison of neuromuscular and idiopathic scoliosis patients. Pediatr Crit Care Med 2002;3:364-9.
30. Edler A, Murray DJ, Forbes RB. Blood loss during posterior spinal fusion surgery in patients with neuromuscular disease: is there an increased risk? Paediatr Anaesth 2003;13:818-22.
31. Garcia-Erce JA, Solano VM, Saez M, et al. Recombinant human erythropoietin facilitates autologous blood donation in children undergoing corrective spinal surgery. Transfusion 2005;45:820-1.
32. Winter SL, Kriel RL, Novacheck TF, et al. Perioperative blood loss: the effect of valproate. Pediatr Neurol 1996;15:19-22.
33. Johnson RG, Murphy M, Miller M. Fusions and transfusions: an analysis of blood loss and autologous replacement during lumbar fusions. Spine 1989;14:358-62.
34. Dekutoski MB. Blood loss and transfusion management in spinal surgery. Orthopedics 1999;22:S155-S157.
35. Chambers HG, Weinstein CH, Mubarak SJ, et al. The effect of valproic acid on blood loss in patients with CP. J Pediatr Orthop 1999;19:792-5.
36. Murphy NA, Firth S, Jorgensen T, et al. Spinal surgery in children with idiopathic and neuromuscular scoliosis. What's the difference? J Pediatr Orthop 2006;26:216-20.
37. Banta JV, Drummond DS, Ferguson RL. The treatment of neuromuscular scoliosis. Instr Course Lect 1999;48:551-62.
38. Glassman SD, Nazar GB, Dimar JR, et al. Neurogenic scoliosis in children. J Ky Med Assoc 1994;92:19-24.
39. Shapiro F, Bresnan MF. Orthopedic management of childhood neuromuscular disease. II. peripheral neuropathies, Friedreich's ataxia, and arthrogryposis multiplex congenital. J Bone Joint Surg Am 1982;64:949-53.
40. McLone DG, Herman JM, Gabrieli AP, et al. Tethered cord as a cause of scoliosis in children with a myelomeningocele. Pediatr Neurosurg 1990-91;16:8-13.
41. Sarwahi V, Sarwark JF, Schafer MF, et al. Standards in anterior spine surgery in pediatric patients with neuromuscular scoliosis. J Pediatr Orthop 2001;21:756-60.
42. Phillips WA, Hensinger RN, Kling TF. Management of scoliosis due to syringomyelia in childhood and adolescence. J Pediatr Orthop 1990;10:351-4.
43. Noordeen MH, Haddad FS, Muntoni F, et al. Blood loss in Duchenne muscular dystrophy: vascular smooth muscle dysfunction? J Pediatr Orthop B 1999;8:212-5.
44. Miyatake M, Miike T, Zhao J, et al. Possible systemic smooth muscle layer dysfunction due to a deficiency of dystrophin in Duchenne muscular dystrophy. J Neurol Sci 1989; 93:11-7.
45. Saito T, Takenaka M, Miyai I, et al. Coagulation and fibrinolysis disorder in muscular dystrophy. Muscle Nerve 2001;3:399-402.